Table 2. Univariate Predictors of the First Appropriate Implantable Cardioverter-Defibrillator Therapy After Generator Replacement.
Risk Factor | HR | 95% CI | P Value |
---|---|---|---|
Left ventricular ejection fraction (per 10% decrement) |
1.48 | 1.16–1.89 | 0.002 |
NYHA functional class (per increase in NYHA class of 1) |
1.72 | 1.18–2.45 | 0.005 |
QRS duration (per increment of 10 ms) | 1.06 | 0.99–1.12 | 0.08 |
Stroke or transient ischemic attack | 1.78 | 0.99–3.21 | 0.055 |
Hemoglobin (per decrement of 1 g/dL) | 1.18 | 1.04–1.35 | 0.011 |
Estimated glomerular filtration rate (per decrement of 10 mL/min 1.73 m2) |
1.12 | 1.02–1.23 | 0.02 |
Blood urea nitrogen (per increment of 10 mg/dL) |
1.14 | 1.03–1.26 | 0.010 |
Serum sodium (per decrement of 10 mEq/L) |
2.18 | 0.97–4.90 | 0.060 |
CI indicates confidence interval; HR, hazard ratio; and NYHA, New York Heart Association.